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Abstract: Aerosolized drug inhalation plays an important role in the treatment of respiratory diseases.
All of the published in silico, in vivo, and in vitro studies have improved the knowledge of aerosol
delivery in the human respiratory system. However, aerosolized magnetic nano-particle (MNP)
transport and deposition (TD) for the specific position of the human lung are still unavailable in the
literature. Therefore, this study is aimed to provide an understanding of the magnetic nano-particle
TD in the targeted region by imposing an external magnetic field for the development of future
therapeutics. Uniform aerosolized nano-particle TD in the specific position of the lung airways will
be modelled by adopting turbulence k–ω low Reynolds number simulation. The Euler–Lagrange
(E–L) approach and the magneto hydrodynamics (MHD) model are incorporated in the ANSYS fluent
(18.0) solver to investigate the targeted nano-particle TD. The human physical activity conditions
of sleeping, resting, light activity and fast breathing are considered in this study. The aerosolized
drug particles are navigated to the targeted position under the influence of external magnetic force
(EMF), which is applied in two different positions of the two-generation lung airways. A numerical
particle tracing model is also developed to predict the magnetic drug targeting behavior in the
lung. The numerical results reveal that nano-particle deposition efficiency (DE) in two different
magnetic field position is different for various physical activities, which could be helpful for targeted
drug delivery to a specific region of the lung after extensive clinical trials. This process will also be
cost-effective and will minimize unwanted side effects due to systemic drug distribution in the lung.
Keywords: pharmaceutical aerosol; magnetic field; magnetic number; targeted drug delivery;
magneto hydrodynamics
1. Introduction
Micron and nano-particles (NPs) are mostly produced from nature (volcanic ash, smoke, ocean
spray, fine sand, and dust, etc.), the workplace (running diesel engines, large-scale mining, and
industry) and man-made processes (fires, traffic, and drug aerosols are generated by inhalers for
therapeutic purposes) [1]. A range of studies [2–12] improved the knowledge of the micron-size
particle transport in the upper and lower airways, while the magnetic nano-particle (MNPs) transport
for targeted drug delivery in literature is greatly missing. The increased popularity of nanomaterial
products expose a significant amount of NP emission into the atmosphere [13]. These NPs or drug
aerosols are inhaled through the extrathoracic and tracheobronchial airways down into the alveolar
region [14]. As a result of strong diffusion and thermophoretic effects, inhaled NPs deposit into
extrathoracic airways [15]. A certain percentage may deposit in various lung regions by touching the
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moist airway surfaces and hence, are accessible for interactions with respiratory tissue [14]. Therefore,
toxic particles may instigate pulmonary and other diseases, while drug aerosols may be harnessed to
struggle with diseases [14,16]. The inhalation of drug aerosols is broadly used for the treatment of
lung disorders such as chronic obstructive pulmonary disease, asthma, respiratory infection, cystic
fibrosis and more recently, lung cancer. NPs significantly influence their retention for shape and size
in the lungs and targeting properties. At present, for drug delivery purposes, NPs are widely used
through various delivery routes, including inhalation. Targeted NP delivery to the affected lung tissue
may improve therapeutic efficiency and minimize unwanted side effects [17]. Despite these attractive
advantages, systemic inhalation of therapeutic drug aerosol delivery in the specific position of the lung
is still not clear [18]. A comprehensive investigation of magnetic nano-particles (MNPs) transport and
deposition (TD) in a lung model is essential for the understanding of pharmaceutical aerosol transport
into the targeted position of the lung.
There are limited studies that have been conducted on MNPs for targeting magnetic drug
delivery. Dames et al. [17] developed superparamagnetic iron oxide nano-particles in a combination
of target-directed magnetic gradient fields for targeting aerosol delivery to the lungs of mice [6].
The theoretical and experimental study concluded that the superparamagnetic iron oxide nano-particles
might be useful for treating specified lung disease. Bennett et al. [19] discussed the potential application
of aerosol drug delivery and deposition techniques for both serial and parallel pathways in the lung [4].
They concluded that aerosol bolus delivery and extremely slow inhalation of aerosols in diagnostic
lung tests might be useful for targeting drug delivery to the conducting airways. Ally et al. developed
an in vitro model to investigate the possibility of targeted magnetic aerosol deposition for lung cancer
and to predict the trajectories of the aerosol particles Ally et al. [20]. They concluded that aerosol
particle concentration and magnetic field gradient are important considerations for targeting magnetic
delivery of aerosols. Mishra et al. [21] focused on the potential application of nanotechnology in
medicine and discussed drug-delivery systems as well as their applications in therapeutics, imaging,
and diagnostics. They concluded that the surface characteristics of NPs could achieve successful
development on targeted NPs to use in therapy and imaging. Wilczewska et al. [22] investigated
the nano carrier connections with drugs and magnetic nano-particles as carriers in drug delivery
systems. The authors concluded that for the drug delivery systems, nanocarriers could improve the
therapeutic and pharmacological properties of conventional drugs. Lübbe et al. [23] reported that
magnetic drug targeting is one of the various possibilities of drug targeting, and site-directed drug
targeting is one way of local or regional antitumor treatment. Sharma et al. [24] studied magnetic
nano-particles transport in a channel for targeted drug delivery. They concluded that the fluid velocity
and MNPs are decreasing with the increasing of a magnetic field. Roa et al. [25] showed that inhalable
doxorubicin NPs are an effective way to treat lung cancer. They revealed that a non-invasive route of
administration might change the way lung cancer is treated in the future. Pourmehran et al. have
used Lagrangian magnetic particle tracking using a discrete phase model to investigate the effect
of a magnetic field on the behavior of the magnetic drug carrier [26]. Pourmehran et al. have used
a realistic model to investigate the human tracheobronchial airways using computational fluid and
particle dynamics [26]. They have developed an optimal magnetic drug characteristics coordination
and magnetic impact for drug delivery to the human lung. Boghi et al. [27] have studied the influence
of magnetic probe position and circulating direction of electric current and geometry they used was the
coeliac trunk for describing MNPs in blood flow. They verified that the effectiveness of their technique
can be the treatment of hepatic cancer. Krafcik et al. [28] have studied MNPs in the single alveolus
using EMF and they concluded that during breathing sedimentation and particle deposition in lung
alveolus is possible. Recently, Russo et al. [29] have used MNPs for targeting drug delivery in the
respiratory airways and showed therapy of a lung tumor but did not consider how much particle or
drug deposited in that targeted position.
Until now there have been no numerical or analytical studies that consider the human respiratory
tract, available in the literature on magnetic nano-particles TD for targeting drug delivery in the
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specific position of the human lung. Hence, detailed analysis of the MNPs transport and deposition
in the human respiratory tract are required for a better understanding of the fluid-particle dynamics.
Therefore, this study presents a two-generation symmetric lung model for targeting drug delivery by
considering two targeting positions.
2. Numerical Methods
The present study considers a two-generation lung model as derived from the trachea, which does
not include the extrathoracic region. ANSYS (Fluent) 18.0 was used to solve the following governing
equations with proper initial and boundary conditions. The steady-state flow field is converged when
the residuals decreased to less than 10−6. Air was considered as the working fluid with constant density
(ρ), viscosity (µ) and fluid static pressure (p). The governing equations for continuity and momentum




























The k-ω low Reynolds number turbulence model is adopted for numerical simulations with
maximum Reynolds number is calculated as 5 × 103. The Reynolds number describes the ratio of the
magnitudes of the inertial and viscous forces on the particle. Due to the presence of extra non-linear
terms [30] there have some limitation of turbulence multiphase flows model [31], however, in the case
of low Reynolds number these terms are negligible.
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The other coefficients value used in the above equation have taken from [26] as follows:
Rβ = 8, Rω = 2.95, Rk = 6, α0 =
1
9
, β0 = 0.0708 , β∗0 = 0.09 ,α
∗
∞ = 1, σω = αk = 0.5
Stationary wall condition, pressure outlet, and velocity inlet conditions are used as the boundary
conditions. For the boundary conditions, wall condition was considered as trap and conducting for the
targeted position, outlet condition was considered as a pressure outlet and turbulence specification
method was κ and omega values, and the inlet condition was considered a uniform mass flow. In this
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analysis deposition efficiency (DE) is identified by calculating trapped particle percentage and the
equation as follows:
DE =
Deposited particle number in the specific position
Total number of injected particle
× 100 (5)
A Lagrangian particle-tracking scheme and finite volume based ANSYS 18.0 (Fluent) solver
together with Euler–Lagrange (E–L) approach and magneto-hydrodynamics (MHD) model have been
applied to investigate the particle TD in the double bifurcation airways model. Euler–Euler [33] and
Euler–Lagrange (E–L) approaches are usually used for nano-particle simulation. An E-L approach
solves the particle trajectory equation while an E–E approach is used to solve convection-diffusion
equations [13]. The E–L method tracks the individual particle trajectory by considering inertia,
electrostatic effects, diffusivity, and near wall terms directly [34]. The present study uses the E–L
approach as it also considers dp ≥ 100 nm. In this approach, the force balance equation for individual
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FM are drag and magnetic forces
respectively. Brownian motion is considered for the present nano-particle simulation. An appropriate






















where Cc is the Cunningham correction factor. The specific correction factor values are used for
different diameter particles. Here ρP and dP are particle density and particle diameter respectively and






where ζ is the unit variance independent Gaussian random number, ∆t is the particle time-step
integration, and S0 is the spectral intensity.
The present study magnetic force,
→











where µ0 is the magnetic permeability, χ is the magnetic susceptibility of the particle, Vp is the particle
volume, and
→
H is the magnetic field intensity.
The magnetic susceptibility of the particle equation [26] is defined as:
χ = −0.14dp · 106 + 0.98 (11)
where, dp is the particle diameter.
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The magnetic number Mn (Tesla) is defined as follows [26]:
Mn = µ0H0 (12)
H0 is the characteristic magnetic field strength. The magnetic number is dependent to the magnetic
field intensity. All case studies that have been used in this analysis to get the desired result are listed in
Table 1.
Table 1. Number of case studies.
Flow Rates
Parameters 7.5 lpm 9 lpm 15 lpm 60 lpm









Magnetic Number Mn = 0.181, 1.5 Mn = 2.5 Mn = 2.5 Mn = 0.181,1.5, 2.5 Mn = 2.5 Mn = 2.5
Magnet Position 1 Position 1 Position 1 Position 1 Position 1 Position 1
Magnet Position 2 Position 2 Position 2 Position 2 Position 2 Position 2 Position 2
3. Computational Domain and Mesh Generation
The two-generation Weibel’s lung model is constructed to calculate the complex flow field in a
human lung. This two-generation lung geometry contains 1.5 million elements and 0.54 million nodes.
An inflation of 10 boundary layer mesh is constructed near the wall as seen in Figure 1.
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Figure 1. (a) Anterior view of the two-generation mesh, (b) interior view and inflation layer mesh near
to the wall, (c) inlet mesh and (d) outlet mesh of 2-generation lung model.
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4. Grid Independence Test
A grid resolution test is performed and an appropriate mesh is adopted for this study.
The numerical model is tested for different grid numbers against maximum pressure, which is
calculated on the outlet plane. As we can see in Figure 2, the result seems converged from the red
point, it is conceivable to use any of the grid cells from this point. However, grid size of 0.54 million
nodes is adopted for the present simulations.
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A comprehensive validation has been performed for the present numerical study.
The two-generation nano-particle simulation results have been compared with various published CFD
and experimental results.
Figure 3 shows the nano-particles DE which is compared with experimental results of a double
bifurcation model (G3-G5) conducted by Kim [35]. The results are validated for the first and second
bifurcation of the present two-generation model. The current model have also been compared with
the CFD result of Zhang and Kleinstreuer [14] for different inlet Reynolds number (Re = 200, 500 and
1000) [35] and Islam et al. for two different inlet Reynolds number (Re = 200, 550) [13]. Figure 3a
shows comparison of nano-particles deposition for the first bifurcation and Figure 3b shows the
deposition comparison for the second bifurcation. The present NPs DE shows good agreement with
both experimental and CFD data published in the literature for both bifurcations.
Figure 4 shows the comparison of nano-particles DF with CFD results of a double bifurcation
model of Zhang and Kleinstreuer [14]. The results are validated for 30 lpm flow rate. It is found that
the present CFD results of DF overlap for both bifurcation with the published results, which confirms
the validity of numerical model.
The model specification and the external magnetic source position have been labelled in Figure 5.
Position 1 and Position 2 indicate the external magnetic field source. Magnet Position 1 has been set
just before the first bifurcation and Position 2 has been set on the right lung, as shown in Figure 5.
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Kleinstreuer [14] across different bifurcation fo 30 lpm flow rates in the bifurcation airway model.
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the right lung (lg2 indicates left Generation 2 and rg2 indicates right Generation 2).
6. Results and Discussion
The present two-generation lung airway model has been designed to calculate the NPs deposition
in the targeted position of the lung. Figure 6 shows the particle TD for three different flow rates which
correspond to sleeping (7.5 lpm), resting (9 lpm) and slow walking (15 lpm) conditions with 1-nm
particle diameter and Mn = 2.5.
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at the targeted Position 1 a d Position 2 are significa tly i creased more than any other region of the
lung. The total percentage of deposition for sleeping breathing condition, at Position 1 and Positio 2
are 96.24 and 41.14, respectively. For 9 lpm flow rate, which represents the resting breathing condition,
the total deposition percentage f r P sition 1 and Position 2 are 56.67 and 39.33 respectively (see
Figure 6c,d). The total percentages of deposition during slow breathing condition (15 lpm flow rate) at
Position 1 and Position 2, are 22.60 and 20.24 respectively, which are shown in Figure 6e, f. From the
deposition scenario of 1-nm diameter particles, it is revealed that under the sleeping condition, a hig er
number of particles are deposited in Position 1 nd Position 2 than any other breathing conditions
considered in this study. Figure 6g shows the overall deposition efficiency for three different flow rates.
The overall depositi n p ttern shows that the Brownian motion is more effective for smaller flow rates.
The effect of Brownian motion is that it increases ith the decrease of flow rates. The overall depositi n
pattern for different flow rates of 1-nm diameter particles satisfies the general assum tion of Brownian
motio and shows that dependi g on the lower flow rates, this Brownian motion is domin nt in the
upper irways. The DE scenario of MNPs, decreases with the increase of flow rat s because of low
residence time.
Figure 7 illustrates the effects of magnetic number (magnetic intensity) at Position 1 and Position
2 with 1nm particles and 7.5 lpm flow rate. Figure 7a,b shows the lung airways deposition scenario for
agnetic nu ber 0.181 at t e tar ete sition 1 siti , r s ti el . he ber of t tal
e ositi erce t s f r a etic er 0.181, at the targete Positio 1 and Position 2 are 74.01
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and 32.41, respectively. The deposited particles for magnetic number 1.5 are shown in Figure 7c,d.
The overall percentage for magnetic number 1.5 at the targeted Position 1 and Position 2 are 74.05 and
40.72, respectively. Figure 7e,f shows the particle deposition at targeted Position 1 and Position 2 for
magnetic number 2.5. The overall deposition percentages for magnetic number 2.5, at the targeted
Position 1 and Position 2 are 96.24 and 41.14, respectively. It is estimated that increasing the magnetic
number deliberately enhances the deposition on the targeted position [26]. From the deposition
scenario of 1-nm diameter particle we found that, under the effect of magnetic number 2.5 and the flow
rate of 7.5 lpm, a higher number of particles are deposited in Position 1 and Position 2 compare to
other magnetic numbers. Figure 7g shows the overall deposition efficiency at the targeted Position 1
and Position 2 for three different magnetic numbers. We found that the larger magnetic number can
play an important role in particulate deposition on the targeted region of the lung. The DE of MNPs
is estimated to be enhanced with the increase of the magnetic number [26]. According to the above
MNPs’ deposition scenario, the deposition value at the targeted region (right lung) is substantially
greater than that at the other region of lung (left lung).
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Figure 8. Particle traces colored by turbulent kinetic energy (k) (m2/S2) for 60 lpm, n = 2.5 and
magnet Position 2, (a) 1-nm, and (b) 1 0-nm.
Figure 9 shows the particle tracing colored by particle residence time at magnet Position 2 for
60 lpm flow rate and Mn = 2.5. Residence times are traced for 1-nm, 10-n , 50-nm, 100-nm, and
500-nm particle diameter. The residence time is the average amount of time spent in a control volume
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by the particles of a fluid. In medical field, the amount of time that a drug spends in the body is usually
referred to by residence time. The residence time of the pharmaceutical aerosol could be different for
different diameter particle. Some of the drug molecules stay in the system for a very short time, while
others may remain for a long time. The overall calculated residence time of the smaller nano-size
particle is found lower than the larger nano-size particle. Figure 9e shows that 500-nm MNPs diameter
spend more time inside the lung than other MNPs diameter residence time.
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The NPs DE comparison in two different magnetic field positions of the two-generation symmetric
lung model at different flow rate and diameter are shown in Figure 10. The DE at two different
magnetic field positions is different for particle diameter and flow rates. Overall DE comparison
shows higher deposition concentration in the magnetic field Position 1 than Position 2. Figure 10
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clearly shows the distinct deposition for different diameter particles at different flow rates for magnetic
number 2.5. Figure 10 also shows the maximum number of particles deposited in Position 1 is 96.244%
for flow rate 7.5 lpm and 1-nm particle diameter. On the other hand, at the targeted Position 2,
the number of deposition percentage is at maximum (70.838) for flow rate 60 lpm and particle diameter
500-nm. The deposition efficiency trend line for flow rate 7.5 lpm shows that when the magnetic
source is in Position 1, the maximum number of particles is deposited for 1-nm diameter than for other
particle sizes.
Table 2 shows the total flow rate and diameter TD percentage comparison across two different
magnetic field position for magnetic number 2.5. Table 2 also shows that the total flow of deposition
concentration is higher in magnetic field Position 1 than in Position 2.
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Table 2. Respiratory particle transport and deposition (TD) comparisons for 1-, 50-, 100- and 500-nm
diameter particles as a function of different breathing airflow rates and magnetic number 2.5.
7.5 lpm 9 lpm 15 lpm 60 lpm
Diameter Position 1 Position 2 Position 1 Position 2 Position 1 Position 2 Position 1 Position 2
1-nm 96.244% 41.146% 56.678% 39.330% 22.606% 20.242% 63.975% 39.907%
50-nm 26.201% 13.871% 30.779% 26.820% 70.724% 18.203% 86.918% 41.595%
100-nm 30.798% 11.450% 21.807% 7.704% 44.401% 13.545% 62.816% 52.719%
500-nm 30.836% 10.934% 47.497% 44.802% 84.529% 23.50% 78.357% 70.838%
Figure 11 illustrates the effects of magnetic number for targeted drug delivery at magnetic
Position 1 and Position 2 with 15 lpm flow rates and 1-nm, 50-nm, 100-nm and 500-nm diameter
particles. The overall deposition is significantly higher for small magnetic number, 0.181 than other
magnetic numbers. The DE trend line for 1-nm particle diameter for 15 lpm breathing condition shows
a linear trend line for Position 1 and Position 2. The deposition trend line of 1-nm, 10-nm and 100-nm
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particle is significantly increased in small magnetic numbers for both magnetic field positions then
decrease as magnetic number increases, shown in Figure 11. The deposition trend lines for 50-nm
and 500-nm are fluctuating during the changes of magnetic number. Due to the position of magnetic
source, the MNPs tend to accelerate along the targeted position in the presence of magnetic intensity.
These specific findings can play an important role in targeted drug delivery.
Table 3 Shows the overall particle TD comparisons at two different targeted positions and different
particle diameters for 0.181, 1.5, and 2.5 magnetic number as a function of 15 lpm slow breathing airflow
rate. Therefore, the smaller magnetic number can play an important role in particulate deposition on
the targeted region of lung during slow breathing condition.
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Table 3. Respiratory particle TD comparisons at two different targeted positions for 0.181, 1.5, and
2.5 magnetic number as a function of 15lpm breathing airflow rates and 1-, 50-, 100- and 500-nm
diameter particle.
Mn Mn = 0.181 Mn = 1.5 Mn = 2.5
Diamet Position Positio Positi Posi P 1 tion 2
1 n 95.275 52.828 51.1 25. . . 2
10 nm 90.228% 15.044% 64.458% 13.625% 27.463% 15.044%
50 nm 92.499% 27.251% 49.132% 14.387% 70.724% 18.203%
100 nm 99.404% 17.146% 77.095% 15.427% 44.401% 13.545%
500 nm 91.647% 0.0193% 97.729% 23.278% 84.529% 23.500%
In order to classify the regional deposition of targeted delivery of NPs, the airway geometry
is specified in three regions according to Figure 5. The local deposition efficiency in each zone at
various inhalation flow rates, particle sizes, and magnetic field position are calculated and shown
in Figure 12. Figure 12a–d symbolize the local deposition efficiency for 7.5 lpm, 9lpm, 15 lpm and
60 lpm flow rates respectively with magnetic number 2.5. Due to external magnetic field being set on
the right lung and before the first bifurcation, the deposition percentage is significantly increased in
Generation 1 of the right lung (rg2). For sleeping (7.5 lpm) and resting (9 lpm) conditions, the regional
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deposition concentration is higher in Generation 1 of 1-nm particle diameters than other regions as it
is seen in Figure 12a,b. Figure 12c shows the region deposition efficiency at two different magnetic
positions for slow breathing condition (15 lpm) and magnetic number 2.5. This figure shows that
maximum regional deposition is held in Generation 1 for 500-nm. Figure 12d shows the overall regional
deposition for fast breathing condition (60 lpm) and magnetic number 2.5. During the fast breathing
pattern, the maximum number of regional depositions is calculated in Generation 1 for 50-nm particles.
The present two-generation symmetrical airway model allows comprehensive NPs deposition data at
different regions, which could potentially increase an understanding of targeted region deposition and
specifically, the transport of magnetic nano-particles to the targeted drug delivery system.
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7. Conclusions
The present double bifurcation symmetric model illustrates comprehensive MNPs TD in the
targeted region of the human lung. The present numerical model shows NPs ranging from 1 ≤ nm ≤ 500
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diameter for sleeping, resting, slow and fast breathing condition of physical activities. A comprehensive
validation has been performed and the following conclusions are drawn from the present study:
• Particle deposition efficiency on the targeted region were investigated as a function of four different
breathing conditions, i.e., 7.5 lpm, 9 lpm, 15 lpm and 60 lpm. The present two-generation lung
model shows that the maximum number of particles deposited in the targeted Position 1 for
7.5 lpm flow rates and in Position 2 for fast breathing condition (60 lpm).
• Particle diameter distribution effects in the targeted two different position were investigated for
1-nm, 50-nm, 100-nm and 500-nm particles. Most of the particle deposited on the targeted position
and right lung (targeted region). The maximum number of depositions in the targeted Position 1
is for 1-nm and 7.5 lpm flow, for 50-nm and 100-nm it is happening for 60 lpm and for 500-nm it is
15 lpm flow rate. On contrary, for targeted Position 2, the deposition concentration is higher in
Position 2 for 500-nm and 60lpm flow rates.
• The deposition scenario was investigated in the targeted position for three different magnetic
number, i.e., 0.181, 1.5 and 2.5. The result shows that the overall deposition concentration is
higher in both magnetic field position for small magnetic number 0.181 and flow rate is 15 lpm.
On contrary, maximum number of the deposited particle in the targeted position are deposited for
magnetic number 2.5 and 7.5 lpm flow rates.
• The nano-particle deposition was investigated for two different magnetic source position, i.e.,
Position 1 (wall position 1) and Position 2. Most of the particle deposited on the wall Position 1,
Generation 1(g1), and rg2 (targeted region). Targeted magnetic particles attracted to the specific
region of the lung, which allows direct treatment of those specific cells. This system reduces
damage to healthy cells in the body.
The obtained results from present study may be used to improve our understanding of realistic drug
delivery system in a targeted position of the human lung.
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